SEARCH RESULTS for GLAXOSMITHKLINE BIOLOGICALS SA

Recent Patent Assignments Patent Assignments - (Total found: 187)

Patent(s) Assignor(s) Orig. Assignee(s) Assignee(s) Reel/Frame

(X0) 13055775: NOVEL COMPOSITIONS AND METHODS

(A1) 20110223200: NOVEL COMPOSITIONS AND METHODS

(B2) 9315556: NOVEL COMPOSITIONS AND METHODS

METTENS, PASCAL

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

26337/989

(X0) 14766202: PHARMACEUTICAL COMPOSITIONS COMPRISING VESICLES

(A1) 20160120818: PHARMACEUTICAL COMPOSITIONS COMPRISING VESICLES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

37054/751

(X0) 13497339: IMMUNODIFFUSION ASSAY FOR INFLUENZA VIRUS

(A1) 20120178185: IMMUNODIFFUSION ASSAY FOR INFLUENZA VIRUS

(B2) 9341623: IMMUNODIFFUSION ASSAY FOR INFLUENZA VIRUS

BARAS, BENOIT GUY JULES

JACOB, VALERIE AUDRY MICHELINE

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

27935/41

(X0) 15003263: FERMENTATION PROCESSES FOR CULTIVATING STREPTOCOCCI AND PURIFICATION PROCESSES FOR OBTAINING CPS THEREFROM

(A1) 20160137973: FERMENTATION PROCESSES FOR CULTIVATING STREPTOCOCCI AND PURIFICATION PROCESSES FOR OBTAINING CPS THEREFROM

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

37571/709

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38754/706

(X0) 14631456: IMMUNOGENIC PROTEINS AND COMPOSITIONS

(A1) 20150343051: IMMUNOGENIC PROTEINS AND COMPOSITIONS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38769/596

(X0) 10543455: Injectable vaccines against multiple meningococcal serogroups

(A1) 20070082014: Injectable vaccines against multiple meningococcal serogroups

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38829/172

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38829/509

(X0) 14357270: IMMUNOGENIC COMPLEXES OF POLYANIONIC CARBOMERS AND ENV POLYPEPTIDES AND METHODS OF MANUFACTURE AND USE THEREOF

(A1) 20140314703: IMMUNOGENIC COMPLEXES OF POLYANIONIC CARBOMERS AND ENV POLYPEPTIDES AND METHODS OF MANUFACTURE AND USE THEREOF

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38829/764

(X0) 13790948: ADJUVANTED FORMULATIONS OF BOOSTER VACCINES

(A1) 20130236492: ADJUVANTED FORMULATIONS OF BOOSTER VACCINES

(B2) 9375471: ADJUVANTED FORMULATIONS OF BOOSTER VACCINES

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38829/915

(X0) 12816534: High-Throughput Complement-Mediated Antibody-Dependent and Opsonic Bactericidal Assays

(A1) 20110312510: High-Throughput Complement-Mediated Antibody-Dependent and Opsonic Bactericidal Assays

(B2) 9365885: High-Throughput Complement-Mediated Antibody-Dependent and Opsonic Bactericidal Assays

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38865/714

(X0) 12374238: VACCINES FOR MALARIA

(A1) 20100150998: VACCINES FOR MALARIA

(B2) 9364525: VACCINES FOR MALARIA

COHEN, JOSEPH D

MARCHAND, MARTINE

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

23466/706

(X0) 14509448: POLYANIONIC POLYMER ADJUVANTS FOR HAEMOPHILUS INFLUENZAE B SACCHARIDE VACCINES

(A1) 20150037368: POLYANIONIC POLYMER ADJUVANTS FOR HAEMOPHILUS INFLUENZAE B SACCHARIDE VACCINES

(B2) 9364533: POLYANIONIC POLYMER ADJUVANTS FOR HAEMOPHILUS INFLUENZAE B SACCHARIDE VACCINES

GARCON, NATHALIE MARIE-JOSEPHE

LEMOINE, DOMINIQUE

WAUTERS, FLORENCE EMILIE JEANNE FRANCOISE

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

36238/948

8158418: CHIMERIC ALPHAVIRUS REPLICON PARTICLES

7572453: CHIMERIC ALPHAVIRUS REPLICON PARTICLES

7531180: CHIMERIC ALPHAVIRUS REPLICON PARTICLES

9255126: CHIMERIC ALPHAVIRUS REPLICON PARTICLES

NOVARTIS VACCINES AND DIAGNOSTICS INC

N/A

N/A

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38903/296

8753651: Capsular polysaccharide solubilisation and combination vaccines

9358278: CAPSULAR POLYSACCHARIDE SOLUBILISATION AND COMBINATION VACCINES

8889152: Capsular Polysaccharides Solubilisation and Combination Vaccines

8852606: CAPSULAR POLYSACCHARIDE SOLUBILISATION AND COMBINATION VACCINES

NOVARTIS AG

N/A

N/A

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38903/319

(X0) 10858858: Immunogenic compositions containing microparticles comprising adsorbed toxoid and polysaccharide-containing antigens

(A1) 20050118275: Immunogenic compositions containing microparticles comprising adsorbed toxoid and polysaccharide-containing antigens

(B2) 9107831: Immunogenic compositions containing microparticles comprising adsorbed toxoid and polysaccharide-containing antigens

NOVARTIS VACCINES AND DIAGNOSTICS INC

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38903/339

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38903/378

(X0) 13982042: ADJUVANT NANOEMULSIONS WITH CRYSTALLISATION INHIBITORS

(A1) 20140017279: ADJUVANT NANOEMULSIONS WITH CRYSTALLISATION INHIBITORS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38903/385

(X0) 14381513: IMMUNOLOGICALLY USEFUL ARGININE SALTS

(A1) 20150125475: IMMUNOLOGICALLY USEFUL ARGININE SALTS

(B2) 9320748: IMMUNOLOGICALLY USEFUL ARGININE SALTS

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38903/441

(X0) 14424370: IMMUNOGENIC COMPOSITION

(A1) 20150224204: IMMUNOGENIC COMPOSITION

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38903/464

(X0) 14760916: Cycloalkyne Derivatized Saccharides

(A1) 20160166704: Cycloalkyne Derivatized Saccharides

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

37977/349

(X0) 14961772: COMPOSITIONS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS

(A1) 20160158335: COMPOSITIONS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38945/527

9364528: COMBINATION NEISSERIAL COMPOSITIONS

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38595/473

(X0) 10822303: Severe acute respiratory syndrome coronavirus

(A1) 20060257852: Severe acute respiratory syndrome coronavirus

NOVARTIS VACCINES AND DIAGNOSTICS INC

GLAXOSMITHKLINE BIOLOGICALS SA

38979/997

(X0) 12836931: RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

(A1) 20110305727: RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38980/20

7731967: COMPOSITIONS FOR INDUCING IMMUNE RESPONSES

8529906: COMPOSITIONS FOR INDUCING IMMUNE RESPONSES

NOVARTIS VACCINES AND DIAGNOSTICS INC

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38980/85

8541023: IMMUNOGENIC COMPOSITIONS CONTAINING PHOSPHOLIPID

8034378: IMMUNOGENIC COMPOSITIONS CONTAINING PHOSPHOLIPID

NOVARTIS VACCINES AND DIAGNOSTICS INC

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38980/129

(X0) 13334739: HIV VACCINE FORMULATIONS

(A1) 20120207783: HIV VACCINE FORMULATIONS

(B2) 8609109: HIV VACCINE FORMULATIONS

NOVARTIS VACCINES AND DIAGNOSTICS INC

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38980/177

8637044: Method of generating an immune response in a subject using fusion proteins comprising CD4 minimal modules and HIV Tat scaffold polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes.

8168194: FUSION PROTEINS COMPRISING CD4 MINIMAL MODULES AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) TAT SCAFFOLD POLYPEPTIDES THAT ARE CAPABLE OF BINDING TO THE HIV ENVELOPE AND EXPOSING CRYPTIC NEUTRALIZATION EPITOPES.

NOVARTIS VACCINES AND DIAGNOSTICS INC

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38980/238

8568734: Method for generating immune responses utilizing nucleic acids encoding fusion proteins comprising CD4 minimal modules and invasin polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes.

8206720: FUSION PROTEINS COMPRISING CD4 MINIMAL MODULES AND INVASIN POLYPEPTIDES THAT ARE CAPABLE OF BINDING TO THE HIV ENVELOPE AND EXPOSING CRYPTIC NEUTRALIZIATION EPITOPES.

NOVARTIS VACCINES AND DIAGNOSTICS INC

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38980/268

(X0) 11710250: MICROPARTICLES CONTAINING BIODEGRADABLE POLYMER AND CATIONIC POLYSACCHARIDE FOR USE IN IMMUNOGENIC COMPOSITIONS

(A1) 20090169636: MICROPARTICLES CONTAINING BIODEGRADABLE POLYMER AND CATIONIC POLYSACCHARIDE FOR USE IN IMMUNOGENIC COMPOSITIONS

(B2) 8431160: MICROPARTICLES CONTAINING BIODEGRADABLE POLYMER AND CATIONIC POLYSACCHARIDE FOR USE IN IMMUNOGENIC COMPOSITIONS

NOVARTIS VACCINES AND DIAGNOSTICS INC

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38980/413

6887462: HSA- FREE FORMULATIONS OF INTERFERON-BETA

7399463: HSA-FREE FORMULATIONS OF INTERFERON-BETA

8333958: HSA-FREE FORMULATIONS OF INTERFERON-BETA

7371373: HSA-FREE FORMULATIONS OF INTERFERON-BETA

7892531: HSA-FREE FORMULATIONS OF INTERFERON-BETA

NOVARTIS VACCINES AND DIAGNOSTICS INC

N/A

N/A

N/A

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38980/459

7811580: CHIMERIC HIV ENV PROTEINS COMPRISING CD4 MINI-PROTEINS OR CD4 MIMETICS THAT ARE CAPABLE OF INDUCING NEUTRALIZING ANTIBODY RESPONSES AGAINST CRYPTIC ENV EPITOPES.

8226955: CHIMERIC HIV ENV PROTEINS COMPRISING CD4 MINI-PROTEINS OR CD4 MIMETICS THAT ARE CAPABLE OF INDUCING NEUTRALIZING ANTIBODY RESPONSES AGAINST CRYPTIC ENV EPITOPES.

8470334: METHOD OF INDUCING AN ANTIVIRAL IMMUNE RESPONSE AGAINST HIV-1 UTILIZING CHIMERIC HIV ENV PROTEINS COMPRISING CD4 MINI-PROTEINS OR CD4 MIMETICS.

NOVARTIS VACCINES AND DIAGNOSTICS INC

N/A

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38980/484

(X0) 09701453: COMBINATION MENINGITIDIS B/C VACCINES

(B1) 8007815: COMBINATION MENINGITIDIS B/C VACCINES

NOVARTIS VACCINES AND DIAGNOSTICS INC

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38980/520

(X0) 13235454: CATIONIC OIL-IN-WATER EMULSIONS

(A1) 20120156251: CATIONIC OIL-IN-WATER EMULSIONS

(B2) 9295646: CATIONIC OIL-IN-WATER EMULSIONS

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38980/585

(X0) 14527851: PURIFICATION OF BACTERIAL VESICLES

(A1) 20150202274: PURIFICATION OF BACTERIAL VESICLES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38980/621

(X0) 13819245: SMALL LIPOSOMES FOR DELIVERY OF IMMUNOGEN ENCODING RNA

(A1) 20130195969: SMALL LIPOSOMES FOR DELIVERY OF IMMUNOGEN ENCODING RNA

(B2) 9254265: SMALL LIPOSOMES FOR DELIVERY OF IMMUNOGEN ENCODING RNA

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38980/827

(X0) 13516227: HOMOGENOUS SUSPENSION OF IMMUNOPOTENTIATING COMPOUNDS AND USES THEREOF

(A1) 20130101629: HOMOGENOUS SUSPENSION OF IMMUNOPOTENTIATING COMPOUNDS AND USES THEREOF

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38980/895

(X0) 13819228: LIPIDS SUITABLE FOR LIPOSOMAL DELIVERY OF PROTEIN CODING RNA

(A1) 20130189351: LIPIDS SUITABLE FOR LIPOSOMAL DELIVERY OF PROTEIN CODING RNA

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38981/996

(X0) 13819007: DISPLACEMENT DESORPTION PROCESS FOR LIGHT OLEFIN SEPARATION

(A1) 20130206581: DISPLACEMENT DESORPTION PROCESS FOR LIGHT OLEFIN SEPARATION

(B2) 9376354: DISPLACEMENT DESORPTION PROCESS FOR LIGHT OLEFIN SEPARATION

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38982/135

(X0) 14343351: METHODS FOR MAKING SACCHARIDE-PROTEIN GLYCOCONJUGATES

(A1) 20140329998: METHODS FOR MAKING SACCHARIDE-PROTEIN GLYCOCONJUGATES

(B2) 9358284: METHODS FOR MAKING SACCHARIDE-PROTEIN GLYCOCONJUGATES

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38982/143

(X0) 13673978: FERMENTATION MEDIA FREE OF ANIMAL-DERIVED COMPONENTS FOR PRODUCTION OF DIPHTHERIA TOXOIDS SUITABLE FOR HUMAN VACCINE USE

(A1) 20130122040: FERMENTATION MEDIA FREE OF ANIMAL-DERIVED COMPONENTS FOR PRODUCTION OF DIPHTHERIA TOXOIDS SUITABLE FOR HUMAN VACCINE USE

(B2) 9040058: FERMENTATION MEDIA FREE OF ANIMAL-DERIVED COMPONENTS FOR PRODUCTION OF DIPHTHERIA TOXOIDS SUITABLE FOR HUMAN VACCINE USE

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38982/247

(X0) 14350575: RECOMBINANT SELF-REPLICATING POLYCISTRONIC RNA MOLECULES

(A1) 20140271829: RECOMBINANT SELF-REPLICATING POLYCISTRONIC RNA MOLECULES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38982/320

(X0) 13670727: Conjugates comprising an antigen and a carrier molecule

(A1) 20130189300: Conjugates comprising an antigen and a carrier molecule

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38982/535

(X0) 14344892: ESCHERICHIA COLI VACCINE COMBINATION

(A1) 20150118261: ESCHERICHIA COLI VACCINE COMBINATION

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38982/612

(X0) 14401024: MENINGOCOCCUS SEROGROUP X CONJUGATE

(A1) 20150104479: MENINGOCOCCUS SEROGROUP X CONJUGATE

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38982/651

(X0) 14130899: IMMUNOGENIC COMBINATION COMPOSITIONS AND USES THEREOF

(A1) 20140227346: IMMUNOGENIC COMBINATION COMPOSITIONS AND USES THEREOF

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38982/776

(X0) 14117588: PRE-FUSION RSV F ANTIGENS

(A1) 20140248314: PRE-FUSION RSV F ANTIGENS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38982/802

(X0) 14130869: IMMUNOGENIC COMPOSITIONS AND USES THEREOF

(A1) 20140242152: IMMUNOGENIC COMPOSITIONS AND USES THEREOF

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38982/827

(X0) 13982206: RSV IMMUNIZATION REGIMEN

(A1) 20140044751: RSV IMMUNIZATION REGIMEN

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38982/855